GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Nfkb1 | increases expression | EXP | | 6480464 | CTD | Bortezomib results in increased expression of NFKB1 mRNA | PMID:35121005 | Nfkb1 | multiple interactions | EXP | | 6480464 | CTD | Berberine inhibits the reaction [Bortezomib results in increased expression of NFKB1 mRNA] | PMID:35121005 | Nfkb1 | decreases expression | ISO | NFKB1 (Homo sapiens) | 6480464 | CTD | Bortezomib results in decreased expression of NFKB1 mRNA; Bortezomib results in decreased expression of NFKB1 protein | PMID:17626072 PMID:25913414 | Nfkb1 | multiple interactions | ISO | NFKB1 (Homo sapiens) | 6480464 | CTD | [Bortezomib co-treated with vorinostat] results in decreased activity of [NFKB1 protein binds to RELA protein]; [resveratrol co-treated with Bortezomib] results in decreased activity of [RELA protein binds to NFKB1 protein]; Bortezomib inhibits the reaction [belinostat results in increased expression of NFKB1 protein]; Bortezomib inhibits the reaction [romidepsin results in increased expression of NFKB1 protein]; Bortezomib promotes the reaction [Fenretinide inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]] | PMID:12893773 PMID:16230421 PMID:17164350 PMID:18223231 | |
Go Back to source page | Continue to Ontology report |